UNSPSC 51184011: Glisolamide

This classification denotes an anti-diabetic agent with the molecular formula C20H26N4O5S, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier (SRS UNII) F83U6T74XR, chemically known as 3-isozazolecarboxamide, n-(2-(4-((((cyclohexylamino)carbonyl)amino)sulfonyl)phenyl)ethyl)-5-methyl- but more generally known as glisolamide, which bears US NIH Compound Identifier 65713. European Medicines Agency schedules Glisolamide in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB07932MIG.

UNSPSC 51184011 Glisolamide is a Commodity code that captures state and local procurement of a specific pharmaceutical compound used in medical and laboratory applications. State and local health departments, hospitals, correctional facilities, and medical research institutions purchase glisolamide for clinical diagnostics, therapeutic use, or laboratory analysis where the compound is indicated. Issuing bodies soliciting under this code span state health and human services departments, county detention and correctional systems, municipal hospitals, and independent health districts. The code appears most active among state-level health procurement offices and regional medical systems managing centralized pharmaceutical inventory.

The source provided contains no recent state or local contract opportunities tagged to UNSPSC 51184011, preventing characterization of current geographic concentration, representative recent solicitations, or specific issuing-body repeat activity. Without posted RFPs, RFQs, or ITBs naming this code, current market signaling under Glisolamide cannot be assessed.